Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis and Rheumatology · Published 2026-07-20 · DOI 10.1002/art.70280

Authors (21)

Philip Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mease, P., Chandran, V., Armstrong, A., et al. (2026). Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial. Arthritis and Rheumatology. https://doi.org/10.1002/art.70280

Related articles

• Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders · Journal of Translational Autoimmunity · 2025 · Cites or is cited by this article
• The Role of IgM Anti‐acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis · Arthritis and Rheumatology · 2026 · Same journal
• Reply · Arthritis and Rheumatology · 2026 · Same journal
• Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis · Arthritis and Rheumatology · 2026 · Same journal
• Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression · Arthritis and Rheumatology · 2026 · Same journal
• Dermatomyositis in skin of color population: expanding clinical recognition · Arthritis and Rheumatology · 2026 · Same journal
• Age‐associated B cells contribute to inflammation via antibody‐independent mechanisms in Takayasu's arteritis · Arthritis and Rheumatology · 2026 · Same journal
• Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real‐world data from the ILD ‐ PRO Registry · Arthritis and Rheumatology · 2026 · Same journal
• Cytokine‐induced NRP2 expression in rheumatoid arthritis fibroblast‐like synoviocytes: comment on the article by Jin et al · Arthritis and Rheumatology · 2026 · Same journal
• Human Fibroblast–Myeloid Cell Tissue Atlas Across the Lungs, Synovium, Skin, and Heart · Arthritis and Rheumatology · 2026 · Same journal